F.L. Putnam Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,191
Closed -$218K 328
2019
Q3
$218K Sell
2,191
-429
-16% -$40.8K 0.02% 274
2019
Q2
$242K Sell
2,620
-43,837
-94% -$4.16M 0.02% 207
2019
Q1
$4.38M Buy
46,457
+731
+2% +$63.9K 0.37% 78
2018
Q4
$2.93M Sell
45,726
-43,286
-49% -$3.2M 0.32% 84
2018
Q3
$7.97M Sell
89,012
-200
-0.2% -$17.7K 0.73% 45
2018
Q2
$7.08M Sell
89,212
-4,573
-5% -$380K 0.69% 52
2018
Q1
$8.37M Sell
93,785
-27,639
-23% -$2.65M 0.77% 45
2017
Q4
$12.7M Sell
121,424
-15,797
-12% -$1.78M 1.16% 27
2017
Q3
$20M Buy
+137,221
New +$18.7M 1.91% 9
2017
Q1
$17.2M Buy
138,438
+23,241
+20% +$2.78M 1.79% 13
2016
Q4
$13.3M Sell
115,197
-3,011
-3% -$335K 1.53% 23
2016
Q3
$12.4M Buy
118,208
+849
+0.7% +$91.9K 1.41% 26
2016
Q2
$11.6M Buy
117,359
+1,575
+1% +$163K 1.37% 27
2016
Q1
$11.6M Buy
115,784
+3,487
+3% +$359K 1.39% 28
2015
Q4
$13.4M Sell
112,297
-19,054
-15% -$2.2M 1.57% 21
2015
Q3
$14.2M Sell
131,351
-985
-0.7% -$122K 1.76% 15
2015
Q2
$15.3M Buy
132,336
+333
+0.3% +$38.1K 1.71% 17
2015
Q1
$15.2M Buy
132,003
+5,725
+5% +$684K 1.7% 13
2014
Q4
$14.1M Sell
126,278
-180
-0.1% -$19K 1.64% 15
2014
Q3
$12M Sell
126,458
-2,168
-2% -$196K 1.41% 20
2014
Q2
$11M Buy
128,626
+13,354
+12% +$1.02M 1.28% 27
2014
Q1
$8.05M Sell
115,272
-18,052
-14% -$1.43M 0.96% 35
2013
Q4
$11.3M Sell
133,324
-28,110
-17% -$2.22M 1.36% 23
2013
Q3
$12.4M Buy
161,434
+60
+0% +$4.21K 1.66% 13
2013
Q2
$9.44M Buy
+161,374
New +$9.71M 1.35% 22

Other funds holding CELG

F.L. Putnam Investment Management's CELG Position: Q4 2019 in Review

F.L. Putnam Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,191 shares — an estimated $218K sold.

F.L. Putnam Investment Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $20M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • F.L. Putnam Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • F.L. Putnam Investment Management sold 2,191 Celgene Corp shares in Q4 2019, an estimated $218K.
  • F.L. Putnam Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • F.L. Putnam Investment Management's Celgene Corp position peaked at $20M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on F.L. Putnam Investment Management's 13F filing for Q4 2019, filed 30 Jan 2020.